Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

1843P - Electro-acupuncture for quality of life in gastric cancer patients undergoing adjuvant chemotherapy

Date

17 Sep 2020

Session

E-Poster Display

Topics

Supportive Care and Symptom Management

Tumour Site

Presenters

Hai-bo Zhang

Citation

Annals of Oncology (2020) 31 (suppl_4): S988-S1017. 10.1016/annonc/annonc291

Authors

H. Zhang1, Y. Zhu1, J.J. Mao2, J. Peng3, X. Chang1, X. Wu4, J. Wan5, W. Wang5, D. Diao5, J. Xiao6, Y. Li7, D. Ma8, M. Hu9, J. Li10, G. Wu4, C. Ke9, K. Sun3, Z. Huang10, T. Cao6, Y. Chen1

Author affiliations

  • 1 Oncology, Guangdong Hospital of Traditional Chinese Medicine, 510120 - Guangzhou/CN
  • 2 Bendheim Integrative Medicine Center, Memorial Sloan Kettering Cancer Center, 10021 - New York/US
  • 3 Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, 510080 - Guangzhou/CN
  • 4 Gastrointestinal Surgery, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, 210000 - Nanjing/CN
  • 5 Gastrointestinal Surgery, Guangdong Hospital of Traditional Chinese Medicine, 510120 - Guangzhou/CN
  • 6 Medical Oncology, the Sixth Affiliated Hospital, Sun Yat-sen University, 510655 - Guangzhou/CN
  • 7 Gastrointestinal Surgery, Guangdong Provincial People's Hospital, 510000 - Guangzhou/CN
  • 8 Gastrointestinal Oncology, Guangdong Provincial People's Hospital, 510180 - Guangzhou/CN
  • 9 Gastrointestinal Surgery, The First Affiliated Hospital of Guangzhou Medical University, 510120 - Guangzhou/CN
  • 10 Gastrointestinal Surgery, Cancer Center of Guangzhou Medical University, 510095 - Guangzhou/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1843P

Background

Gastrectomy followed by adjuvant chemotherapy (chemo) remains preferred strategy for local gastric cancer. However, quality of life (QoL) declines post-operatively, due to both surgery and chemotherapy. This pilot study (NCT03753399) aimed at evaluating the preliminary effect of electro-acupuncture (EA) for improving quality of life in gastric cancer patients undergoing adjuvant chemotherapy.

Methods

Patients who has accepted R0 resection for gastric cancer, and who will receive adjuvant chemotherapy were randomly assigned to receive high-dose of EA (7 times each chemo-cycle for 3 cycles), low-dose of EA (3 times each chemo-cycle for 3 cycles), or no acupuncture. Functional Assessment of Cancer Therapy-Gastric (FACT-Ga) was reported by the patients at baseline and then once a week during the therapy. Primary endpoint was the total area under curves (AUCs) of FACT-Ga Trial Outcome Index (TOI) during the 3 cycles of chemotherapy, calculated by linear interpolation, among the groups. Secondary endpoints included the AUCs of FACT-Ga Gastric Cancer Subscale (GaCS), and FACT-Ga score among the groups.

Results

Of the randomized 66 patients, 45 (68.18%) were analyzed in the per-protocol set (PPS). Electro-acupuncture, both high-dose and low-dose, although not significantly, produced trend of QoL improvement. AUCs (21 days/cycle × 3 cycles), the higher, the better, of TOI in the PPS were 5360±1120, 5443±1313, and 4780±840 (p=0.188), of GaCS were 3273±591, 3261±757, and 2865±534 (p=0.126), and of FACT-Ga were 7731±1587, 7979±1702, and 7084 ±1183 (p=0.231), in high-dose EA group, low-dose EA group, and control group, respectively. When combining patients in the two EA groups, TOI (5402±1198 vs. 4780±840, p=0.048) and GaCS (3267±666 vs. 2865±534, p=0.041) AUCs of EA patients were significantly higher than those in control group. AUCs of FACT-Ga in EA patients were also higher than those in control group, although the difference was not statistically significant (7855±1620 vs. 7085±1183, p=0.074).

Conclusions

Electro-acupuncture was associated with promising effect in improving quality of life during adjuvant chemotherapy in gastric cancer patients. Future adequately powered trial is needed to confirm the specific effect.

Clinical trial identification

NCT03753399 first release: November 27, 2018.

Editorial acknowledgement

Legal entity responsible for the study

Hai-bo Zhang.

Funding

The National Key Research and Development Program of China (2017YFC1700603); The Science and Technology Planning Project of Guangdong Province (2017A020213021).

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.